Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Michael Kirshenbaum, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chai PR, Ferro EG, Kirshenbaum JM, Hayes BD, Culbreth SE, Boyer EW, Erickson TB. Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic. J Med Toxicol. 2020 07; 16(3):314-320. PMID: 32514696.
    Citations:    
  2. Berg DD, Kirshenbaum JM, Gay E, Miller AL, Loscalzo J. A Dangerous Detour. N Engl J Med. 2019 Apr 04; 380(14):1360-1365. PMID: 30943341.
    Citations:    
  3. Berg DD, Kirshenbaum J, Gay E, Vaidya A, Loscalzo J. A Dangerous Detour. N Engl J Med. 2019 Mar 28; 380(13):e18. PMID: 30917263.
    Citations:    
  4. Dempsey J, Gillis C, Sibicky S, Matta L, MacRae C, Kirshenbaum J, Faxon D, Churchill W. Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population. Am J Health Syst Pharm. 2018 Sep 01; 75(17 Supplement 3):S63-S71. PMID: 29976830.
    Citations:    Fields:    
  5. DeFilippis EM, Vaidya A, Ramani S, French C, Kirshenbaum JM. Under Pressure. N Engl J Med. 2017 Mar 30; 376(13):e23. PMID: 28355512.
    Citations:    Fields:    Translation:Humans
  6. Horgan SJ, Waller AH, Veeranna V, Kirshenbaum J, Dorbala S, Di Carli MF. Utility of multimodality imaging in suspected prosthetic valve endocarditis. J Nucl Cardiol. 2016 Apr; 23(2):316-20. PMID: 26607362.
    Citations:    Fields:    Translation:Humans
  7. Hucker WJ, Chatzizisis YS, Steigner ML, Winters GL, Kirshenbaum JM. Myocardial catastrophe: a case of sudden, severe myocardial dysfunction. Circulation. 2014 Sep 02; 130(10):854-62. PMID: 25210096.
    Citations:    Fields:    Translation:Humans
  8. Bittencourt MS, Christman MP, Hulten E, Divakaran S, Skali H, Kwong RY, Hainer J, Forman DE, Kirshenbaum JM, Dorbala S, Di Carli MF, Blankstein R. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11. PMID: 24874162.
    Citations: 2     Fields:    Translation:Humans
  9. Marchini J, Morrow D, Resnic F, Manica A, Kirshenbaum J, Cannon C, Croce K. An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention. Crit Pathw Cardiol. 2010 Dec; 9(4):192-8. PMID: 21119336.
    Citations: 2     Fields:    Translation:Humans
  10. Punnoose LR, Roh JD, Hu S, Udell JA, Wagle N, Kirshenbaum JM, Lacasce AS. Cardiac presentation of anaplastic large-cell lymphoma. J Clin Oncol. 2010 Jul 01; 28(19):e314-6. PMID: 20516445.
    Citations:    Fields:    Translation:Humans
  11. Maron BA, Goldhaber SZ, Sturzu AC, Rhee DK, Ali BS, Shah PB, Kirshenbaum JM. Catheter-directed thrombolysis for giant right atrial thrombus. Circ Cardiovasc Imaging. 2010 Jan; 3(1):126-7. PMID: 20086226.
    Citations:    Fields:    Translation:Humans
  12. Goldszer RC, Moore ML, Hird L, Kirshenbaum JM, et al. . Process improvements to support eairler discaharge times on a cardiology serviece. J of Clinical Outcomes Management. 2003; 10:263-265.
  13. Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003 Jan; 145(1):42-6. PMID: 12514653.
    Citations: 37     Fields:    Translation:Humans
  14. Simon DI, Liu CB, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Popma JJ. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv. 2001 Apr; 52(4):425-32. PMID: 11285593.
    Citations: 3     Fields:    Translation:HumansCells
  15. Pierce GL, Seferlis C, Kirshenbaum J, Hartley LH. Lack of association of exercise testing with coronary stent closure. Am J Cardiol. 2000 Dec 01; 86(11):1259-61, A6. PMID: 11090804.
    Citations:    Fields:    Translation:Humans
  16. Delacretaz E, Kirshenbaum JM, Friedman PL. Prinzmetal's angina. Circulation. 2000 Mar 21; 101(11):E107-8. PMID: 10725300.
    Citations:    Fields:    Translation:Humans
  17. Lin CB, Popma JJ, Chan S, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Simon DI. Comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergiong percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Circulation. 2000; 102:II-418.
  18. Stone PH, Thompson B, Zaret BL, Chaitman B, Gibson RS, Schweiger MJ, Steingart R, Kirshenbaum J, Thompson C, Fung A, McCabe CH, Knatterud GL, Braunwald E. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study. Eur Heart J. 1999 Aug; 20(15):1084-93. PMID: 10413638.
    Citations: 4     Fields:    Translation:Humans
  19. Kirshenbaum JM. Management of Stable and Unstable Angina Pectoris. Physicians on Line: Controversies in Cardiology CME. 1998.
  20. Cannon CP, Thompson B, McCabe CH, Mueller HS, Kirshenbaum JM, Herson S, Nasmith JB, Chaitman BR, Braunwald E. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials. Am J Cardiol. 1995 May 15; 75(15):977-81. PMID: 7747698.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  21. Hauptman PJ, Pashos CL, Kirshenbaum JM, Guadagnoli E, Flather MD. Clinical Dilemas and Policy Controversies in Early Management of Acute Myocardial Infarction. JCOM. 1995; 2:9-30.
  22. Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol. 1994 Dec; 24(7):1602-10. PMID: 7963104.
    Citations: 25     Fields:    Translation:HumansCTClinical Trials
  23. Hickey ML, Rossi L, Vander Vliet M, Kirshenbaum JM, Komaroff AL, Lee TH, Burstin H. Gender differences in health status prior to coronary revascularization. Circulation. 1994; 90(Suppl I):I-349.
  24. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI-IIIB trial. Circulation. 1994; 89:1545-1156.
  25. Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, Palmeri S, Dangoisse V, Flaker GC, Davis V, Chaitman, Wackers FJTh, Zaret BL, Gibson CM, Poole WK, Braunwald E. Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial. Circulation. 1993; 88(Suppl I):I-291.
  26. Kirshenbaum JM. Therapy for acute myocardial infarction: an update. Heart Dis Stroke. 1992 Jul-Aug; 1(4):211-7. PMID: 1364244.
    Citations:    Fields:    Translation:Humans
  27. Kirshenbaum JM. Therapy of Acute Myocardial Infarction: An Update. Heart Disease and Stroke. 1992; 1:211-217.
  28. Kirshenbaum JM, Bahr RD, Flaherty JT, Gurewich V, Levine HJ, Loscalzo J, Schumacher RR, Topol EJ, Wahr DW, Braunwald E. Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group. Am J Cardiol. 1991 Dec 15; 68(17):1564-9. PMID: 1746455.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  29. Carvalho PA, Vekshtein VI, Tumeh SS, Alajaji G, Nagel JS, Kirshenbaum J, DeSisto WC, Holman BL. Tc-99m MIBI SPECT in the assessment of myocardial reperfusion after percutaneous transluminal coronary angioplasty. Clin Nucl Med. 1991 Nov; 16(11):819-25. PMID: 1752091.
    Citations: 1     Fields:    Translation:Humans
  30. Ryan TJ, Kirshenbaum JM. Coronary angioplasty in acute myocardial infarction. J Myocardial Ischemia. 1991; 3:37-50.
  31. Tischler MD, Lee RT, Kirshenbaum JM. Successful treatment of prosthetic tricuspid valve thrombosis with short-course recombinant tissue-type plasminogen activator. Am Heart J. 1990 Oct; 120(4):975-7. PMID: 2121011.
    Citations: 1     Fields:    Translation:Humans
  32. Kirshenbaum JM, Flaherty JT, Bahr RD, Levine HJ, Loscalzo J, Schumacher R, Topol EJ, Wahr D, and Braunwald E. Coronary thrombolysis with low-dose synergistic combinations of prourokinase and recombinant tissue plasminogen activator. Circulation. 1990; 82((Suppl III):III-537.
  33. Kuo PC, Kirshenbaum JM, Gordon J, Laffel G, Young P, DiSesa VJ, Mudge GH, Vaughan DE. Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Am J Cardiol. 1989 Sep 15; 64(10):631-5. PMID: 2675584.
    Citations: 4     Fields:    Translation:Humans
  34. Kirshenbaum JM. Nonthrombolytic intervention in acute myocardial infarction. Am J Cardiol. 1989 Jul 18; 64(4):25B-28B. PMID: 2568748.
    Citations:    Fields:    Translation:HumansAnimals
  35. Loscalzo J, Wharton TP, Kirshenbaum JM, Levine HJ, Flaherty JT, Topol EJ, Ramaswamy K, Kosowsky BD, Salem DN, Ganz P, et al. Clot-selective coronary thrombolysis with pro-urokinase. Circulation. 1989 Apr; 79(4):776-82. PMID: 2494004.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  36. Lee RT, Bhatia SJ, Kirshenbaum JM, Friedman PL. Left ventricular tamponade: echocardiographic and hemodynamic manifestations. Clin Cardiol. 1989 Feb; 12(2):102-4. PMID: 2714028.
    Citations: 2     Fields:    Translation:Humans
  37. Kirshenbaum JM. Thrombolysis and angioplasty in acute myocardial infarction. Management Options in Cardiology. 1989; 1:4-5.
  38. Stamler JS, Vaughan DE, Rudd MA, Mudge GH, Kirshenbaum J, Young P, Alexander RW, Loscalzo J. Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol. 1988 Dec 01; 62(17):1268-72. PMID: 3057854.
    Citations: 13     Fields:    Translation:Humans
  39. Kirshenbaum JM, Kloner RF, McGowan N, Antman EM. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol. 1988 Sep; 12(3):773-80. PMID: 2900259.
    Citations: 3     Fields:    Translation:Humans
  40. Vaughan DE, Kirshenbaum JM, Loscalzo J. Streptokinase-induced, antibody-mediated platelet aggregation: a potential cause of clot propagation in vivo. J Am Coll Cardiol. 1988 Jun; 11(6):1343-8. PMID: 3130418.
    Citations: 1     Fields:    Translation:Humans
  41. Manji N, Hulyalkar AR, Keroack MA, Vekshtein VI, Kirshenbaum JM, Sugarman DI, Chopra S. Cutaneous pseudo abscesses: an unusual presentation of severe pancreatitis. Am J Gastroenterol. 1988 Feb; 83(2):177-9. PMID: 3341343.
    Citations:    Fields:    Translation:Humans
  42. Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988 Jan; 81(1):21-31. PMID: 3121675.
    Citations: 18     Fields:    Translation:Humans
  43. Bhatia SJ, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ, Young PJ, Mudge GH, Sutton MG. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 1987 Oct; 76(4):819-26. PMID: 3308165.
    Citations: 9     Fields:    Translation:Humans
  44. Brasier AR, Macklis JD, Vaughan D, Warner L, Kirshenbaum JM. Myopericarditis as an initial presentation of meningococcemia. Unusual manifestation of infection with serotype W135. Am J Med. 1987 Mar 23; 82(3 Spec No):641-4. PMID: 3103444.
    Citations: 5     Fields:    Translation:HumansCells
  45. Vaughan DE, Kirshenbaum JM, Loscalzo J. Platelet aggregation induced by streptokinase in the presence of specific antibodies. Circulation. 1987; 76(Suppl IV):IV-100.
  46. Kirshenbaum JM, Antman E, McGowan N, Kloner P. Use of esmolol in patients with acute myocardial ischemia and contraindications to beta blockade. J Am Coll Cardiol. 1987; 9(Suppl A):24A.
  47. Bhatia S, Kirshenbaum JM, Shemin R, Cohn L, Collins J, DiSesa V, Mudge G, St. John Sutton M. Time course of resolution of pulmonary hypertension and right ventricular remodeling after cardiac transplantation. J Am Coll Cardiol. 1987; 9(Suppl A):31A.
  48. Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P. Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation. 1986 Aug; 74(2):330-9. PMID: 2942314.
    Citations: 11     Fields:    Translation:Humans
  49. Sung RJ, Blanski L, Kirshenbaum J, MacCosbe P, Turlapaty P, Laddu AR. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia. J Clin Pharmacol. 1986 03; 26(S1):A15-A26. PMID: 2870082.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  50. Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Dozlowski J, English RJ, Jones AG. The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99-m hexakis (t-butylisonitrile) technetium (I) (TBI), a new myocardial imaging agent. European J Nucl Med. 1986; 12:219-225.
  51. Shemin RJ, Young P, Kirshenbaum JM, Mudge GH, Schoen F, DiSesa VJ, Cohn LH, Collins JJ. Acute rejection: Treatment results in a new heart transplant program. J Heart Transp. 1986; 5:53.
  52. Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Kozlowski J, English RJ, Jones AG. The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent. Eur J Nucl Med. 1986; 12(5-6):219-25. PMID: 3780766.
    Citations: 5     Fields:    Translation:Humans
  53. Levin DC, Boxt LM, Abben R, Garnic JD, Kirshenbaum JM, Adler D, Shook T, Friedman P, Ganz P. Sequential balloon technique in angioplasty of severe coronary arterial obstructions. Am J Cardiol. 1985 Nov 01; 56(12):789-91. PMID: 2932904.
    Citations:    Fields:    Translation:Humans
  54. Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol. 1985 Oct 23; 56(11):40F-48F. PMID: 2864848.
    Citations: 6     Fields:    Translation:HumansAnimalsCTClinical Trials
  55. Kirshenbaum JM, Kloner RA, Antman EM, Braunwald E. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation. 1985 Oct; 72(4):873-80. PMID: 2863013.
    Citations: 10     Fields:    Translation:Humans
  56. Kirshenbaum JM, Lorell BH, Schoen FJ, Bettmann MA, Thompson GB. Angioinvasive pulmonary aspergillosis: presentation as massive pulmonary saddle embolism in an immunocompromised patient. J Am Coll Cardiol. 1985 Aug; 6(2):486-9. PMID: 3894476.
    Citations: 1     Fields:    Translation:HumansAnimals
  57. Kirshenbaum JM, Smith TW. Mitral valve surgery: Reconstruction vs. Replacement. Lifeline. 1985; 3:1-16.
  58. Campbell S, Holman BL, Kirshenbaum JM, Jones AG, Lister-James J, Davison, A. Antman EM. Radionuclide imaging of myocardial infarction using Tc-99m TBI. Circulation. 1985; 72(Suppl III):III-443.
  59. Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ. A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human. J Nucl Med. 1984 Dec; 25(12):1350-5. PMID: 6334145.
    Citations: 30     Fields:    Translation:Humans
  60. Shook TL, Kirshenbaum JM, Hundley RF, Shorey JM, Lamas GA. Ethanol intoxication complicating intravenous nitroglycerin therapy. Ann Intern Med. 1984 Oct; 101(4):498-9. PMID: 6433764.
    Citations: 2     Fields:    Translation:Humans
  61. Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ. A new Tc-99m-labeled myocardial imaging agent, hexakis (t-utylisonitrile-technetium (I) (Tc-99m TBI): initial experience in the human. J Nucl Med. 1984; 25:1350-1355.
  62. Kirshenbaum JM, Stone PH. Left main artery disease: noninvasive detection. Primary Cardiology. 1984; 10:87-101.
  63. Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE. Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther. 1981 Mar; 29(3):318-21. PMID: 7471601.
    Citations: 11     Fields:    Translation:Humans
  64. Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE . Effect of large doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharm Ther. 1981; 29:318-321.
  65. Wheeler JE, Enterline HT, Roseman JM, Tomasulo JP, McIlvaine CH, Fitts WT, Kirshenbaum J. Lobular carcinoma in situ of the breast. Long-term followup. Cancer. 1974 Sep; 34(3):554-63. PMID: 4853024.
    Citations: 30     Fields:    Translation:Humans
  66. Fox RR, Laird CW, Kirshenbaum J, Meier H. Effect of strain, sex, and circadian rhythm on rabbit serum bilirubin and iron levels. Proc Soc Exp Biol Med. 1974 Feb; 145(2):421-7. PMID: 4814137.
    Citations: 1     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kirshenbaum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (242)
Explore
_
Co-Authors (39)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.